Financial Performance - The company reported a total revenue of RMB 1.2 billion for the year 2020, representing a year-on-year increase of 15%[14]. - The net profit attributable to shareholders was RMB 150 million, which is a 10% increase compared to the previous year[14]. - Future guidance estimates a revenue growth of 20% for 2021, driven by new product launches and market expansion efforts[14]. - The company's operating revenue for 2020 was ¥265,756,701.42, representing an increase of 1,810.29% compared to ¥13,911,871.59 in 2019[21]. - The net profit attributable to shareholders for 2020 was ¥17,990,173.81, a 276.72% increase from a loss of ¥10,180,311.64 in 2019[21]. - The company achieved operating revenue of 265.76 million yuan, with a net profit of 31.33 million yuan, and a net profit attributable to shareholders of 17.99 million yuan, representing a year-on-year increase of 276.72%[69]. - The total operating revenue for 2020 reached ¥265,756,701.42, representing a significant increase of 1,810.29% compared to ¥13,911,871.59 in 2019[80]. - The gross profit margin for the manufacturing sector was 23.34%, with operating costs amounting to ¥196,563,463.21[82]. Business Strategy and Market Expansion - The company has outlined a market expansion strategy targeting Southeast Asia, aiming for a 30% increase in market share within the next two years[14]. - The company is exploring potential mergers and acquisitions to enhance its product offerings and market presence[14]. - The company is positioned to expand into the biopharmaceutical and new chemical sectors as part of its strategic transformation[68]. - The company aims to become a full industry chain company in the fine chemical industry within the next 2-3 years, focusing on research, production, and sales[120]. - The company plans to invest in a 3-methylpyridine production line to secure raw material supply and enhance profitability[121]. Research and Development - The company plans to invest RMB 200 million in research and development for new products and technologies in 2021[14]. - Research and development expenses amounted to ¥8.50 million, representing 3.20% of total revenue, with a 100% increase in R&D personnel to 64[95]. - The company holds three invention patents and eight utility model patents, showcasing its strong R&D capabilities in the production of pyridine derivatives[58]. Risk Management - The company has identified key risks including market competition and regulatory changes, with strategies in place to mitigate these risks[5]. - Market risks are present due to dependence on the downstream pharmaceutical and agricultural sectors, which could adversely affect performance if market expansion is below expectations[123]. - Raw material price fluctuations pose a significant risk, as they constitute a large portion of operating costs, potentially impacting profitability if costs cannot be passed on[123]. - The company faces risks related to performance compensation and share buyback obligations from major asset restructuring, which may not be guaranteed[124]. Asset Management and Financial Position - The company’s total assets as of December 31, 2020, were valued at RMB 3 billion, reflecting a 5% increase from the previous year[14]. - The company's total assets at the end of 2020 reached ¥727,396,395.77, a 202.59% increase from ¥240,391,225.91 at the end of 2019[21]. - The total assets of the company reached 727.40 million yuan, an increase of 202.59% compared to the same period last year, with a debt-to-asset ratio of 68.13%[69]. - As of the end of 2020, cash and cash equivalents amounted to ¥47,629,290.74, representing 6.55% of total assets, an increase from 6.03% at the beginning of the year[101]. Corporate Governance and Shareholder Relations - The company has established a new board of directors and supervisory board, completing the nomination and election process by December 2020[70]. - The company reported a total of 53 investor communications throughout the year, indicating active engagement with stakeholders[129]. - The company has not disclosed any significant undisclosed information during its investor communications[129]. - The company has made commitments regarding related party transactions to ensure fair market principles are followed[148]. Environmental and Compliance Commitments - The company is focusing on green chemistry and safety regulations in response to increasing government emphasis on environmental protection[56]. - The company is committed to "green chemistry" practices in response to increasing environmental protection regulations, ensuring compliance with national and industry standards[122]. - The company has established a commitment to normal performance in various operational aspects, including property rights management and system certifications[166]. Transition from Real Estate to Fine Chemicals - The company transitioned its main business from real estate to fine chemical products, specifically focusing on the research, production, and sales of pharmaceutical and pesticide intermediates[30]. - The company successfully divested its loss-making real estate business and transitioned to the more profitable fine chemicals industry, focusing on the research, production, and sales of pharmaceutical and pesticide intermediates[90]. - The company completed the acquisition of a 51% stake in Hebei Yano Biological Technology Co., Ltd. in June 2020, and sold an 84.156% stake in Lanzhou Tongchuang Jiaye Real Estate Development Co., Ltd.[57]. Production and Supply Chain - The company operates a direct procurement model for raw materials, ensuring quality through a rigorous supplier evaluation process[42]. - The main raw materials include 3-methylpyridine, liquid ammonia, and dimethyl sulfate, with energy sources being electricity, steam, and water[44]. - The production capacity for 3-Cyanopyridine is 13,500 tons per year with a utilization rate of 64%, while MNO has a capacity of 500 tons with a 99% utilization rate, and 2-Chloronicotinic Acid has a capacity of 2,000 tons with a 47% utilization rate[74]. Commitments and Future Outlook - The company has committed to achieving net profits of no less than RMB 45 million, RMB 53 million, and RMB 62 million for the years 2020, 2021, and 2022 respectively, totaling a commitment of RMB 160 million[172]. - The company will ensure compliance with the latest regulatory requirements regarding compensation measures[195]. - The company is actively pursuing legal actions to recover investments and has engaged legal counsel for assistance[198].

Financial Performance - The company's operating revenue for Q1 2021 reached ¥138,055,660.87, a 100% increase compared to the same period last year[8]. - Net profit attributable to shareholders was ¥8,142,890.27, representing a 63.33% increase year-on-year[8]. - The net profit after deducting non-recurring gains and losses was ¥8,142,890.27, a significant increase of 762.64% compared to a loss of ¥1,228,853.16 in the previous year[8]. - The net cash flow from operating activities improved to ¥3,343,996.70, a 116.13% increase from a negative cash flow of ¥20,732,670.73 in the same period last year[8]. - The company reported a significant increase in total assets, reflecting a strong financial position[39]. - The total profit for the quarter reached CNY 20,757,129.53, up from CNY 4,921,809.78 year-over-year[112]. - Basic and diluted earnings per share increased to CNY 0.0252 from CNY 0.0154 in the previous year[113]. - The company reported a net loss of CNY 389,723,804.90 in retained earnings, slightly improved from a loss of CNY 397,866,695.17[106]. Assets and Liabilities - Total assets at the end of the reporting period were ¥761,669,636.81, up 4.71% from the end of the previous year[8]. - The company's total liabilities reached CNY 512,436,484.58, an increase from CNY 495,566,567.31 in the previous period[106]. - The total current liabilities decreased to CNY 115,000,000.00 from CNY 115,000,000.00, remaining stable[104]. - The company's long-term assets, including fixed assets, were valued at CNY 246,572,752.60, down from CNY 253,347,132.46, a decrease of approximately 2.7%[104]. - The total non-current assets amounted to CNY 482,836,802.27, slightly down from CNY 484,886,168.70, a decrease of about 0.4%[104]. Cash Flow - Cash flow from operating activities generated a net amount of CNY 3,343,996.70, a recovery from a negative cash flow of CNY 20,732,670.73 in the same quarter last year[120]. - The company reported a significant increase in cash inflow from operating activities, totaling CNY 86,097,583.64 compared to CNY 3,943,062.47 in the previous year[120]. - Cash flow from financing activities showed a net outflow of CNY 4,925,847.09, compared to a net inflow of CNY 18,900,000.00 in the previous period[121]. - The net cash and cash equivalents decreased by CNY 2,442,810.24, while the beginning balance was CNY 16,232,461.16, resulting in an ending balance of CNY 13,789,650.92[121]. Research and Development - Research and development expenses for the period amounted to ¥4,576,100, reflecting increased investment in R&D[16]. - The company incurred research and development expenses of CNY 4,576,108.28 during the quarter[111]. Corporate Governance and Compliance - The company has committed to maintaining its independence and ensuring that its management and financial personnel do not hold positions in other companies controlled by the parent company[25]. - The company has established a complete governance structure to maintain operational independence from its controlling shareholders[27]. - The company guarantees that it will not engage in any business that competes with the listed company and its subsidiaries[27]. - The company has pledged to ensure that its financial personnel do not hold dual positions in controlled enterprises, maintaining financial independence[71]. - The company has committed to not engaging in any business that competes with Lingang Yano Chemical after the completion of the restructuring[66]. Strategic Restructuring - The company completed a major asset restructuring in June 2020, transitioning from the real estate industry to the fine chemical industry[17]. - The company plans to sell 84.156% of its stake in Lanzhou Tongchuang Jiaye Real Estate Development Co., Ltd. as part of its strategic restructuring[42]. - The company has committed to ensuring that the wastewater treatment facility will only be used by 临港亚诺化工 and will not be provided to any third parties[58]. Investor Relations - The company is actively engaging with investors regarding its strategic planning and performance forecasts, indicating a focus on transparency and investor relations[97]. - The company has been addressing inquiries related to stock price fluctuations, demonstrating its commitment to investor communication and market stability[97]. Commitments and Obligations - The company has made commitments regarding asset restructuring to ensure that any dilution of immediate returns is effectively addressed[37]. - The company has committed to ensuring that the wastewater treatment facility will only be used by 临港亚诺化工 and will not be provided to any third parties[58]. - The company has pledged to comply with the latest regulations set by the securities regulatory authorities regarding compensation measures[82]. - The company has acknowledged the legal responsibilities for any losses caused to investors due to violations of commitments[83].

Financial Performance - Operating revenue reached CNY 112,366,904.71, reflecting a significant increase of 1,404.04% year-on-year[7] - Net profit attributable to shareholders was CNY 3,569,525.62, up 244.94% compared to the same period last year[7] - Basic earnings per share increased by 244.74% to CNY 0.0110[7] - Operating revenue from the beginning of the year to the reporting period is 177,215,664.47 CNY, an increase of 1404.04% compared to 11,782,613.02 CNY in the same period last year[18] - Operating costs for the same period are 135,811,521.96 CNY, an increase of 997.89% compared to 12,370,266.64 CNY in the same period last year[18] - The net profit for the period reached CNY 9,228,993.23, a turnaround from a net loss of CNY 2,749,888.68 in the previous period[85] - The company reported a gross profit margin of approximately 10.1% for the quarter, reflecting improved operational efficiency[85] - The estimated cumulative net profit for the year is projected to be between 21 million and 27 million yuan, representing a growth of 306.28% to 365.22% compared to the same period last year[65] - Basic earnings per share are expected to be between 0.0650 and 0.0835 yuan, reflecting an increase of 306.35% to 365.08% year-on-year[65] Assets and Liabilities - Total assets increased by 192.05% to CNY 702,069,572.91 compared to the end of the previous year[7] - Total liabilities rose to CNY 474,412,836.17, compared to CNY 152,363,231.59 at the end of 2019, marking an increase of around 211.5%[77] - The company's equity attributable to shareholders increased to CNY 95,928,208.60 from CNY 75,234,542.75, reflecting a growth of approximately 27.5%[78] - Current assets reached CNY 213,800,468.16, up from CNY 201,165,583.06, indicating a growth of about 6.9% year-over-year[75] - The total liabilities were CNY 240,543,863.54, with current liabilities constituting CNY 239,298,438.54[81] - The total assets of the company stood at CNY 328,345,620.88, indicating a solid asset base[81] - Total inventory decreased to CNY 110,921,304.76 from CNY 143,557,508.60, a decline of about 22.7%[75] - The company has long-term equity investments valued at CNY 67,222,436.63, indicating a strategic focus on investment growth[111] Cash Flow - Net cash flow from operating activities surged by 1,519.89% to CNY 63,164,381.34[7] - The net cash flow from operating activities is 49,137,792.90 CNY, a growth of 3046.45% compared to -1,667,692.57 CNY in the same period last year[19] - The net cash flow from investing activities is -49,850,144.11 CNY, primarily due to significant asset restructuring[19] - The net cash flow from financing activities is 18,351,003.03 CNY, an increase of 3418.91% compared to -552,922.41 CNY in the same period last year[19] - Total cash and cash equivalents at the end of the period reached ¥28,722,050.84, an increase of ¥16,778,671.27 from the previous period[101] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 19,295[11] - The top ten shareholders collectively hold 39.60% of the company's shares, with Beijing Dashi Investment Co., Ltd. holding 9.97%[11] - The company holds 32,220,200 shares, accounting for 9.97% of the total share capital of the listed company[26] - Upon completion of the equity change, the company and its concerted parties will collectively own 26.90% of the total share capital of the listed company[26] Commitments and Compliance - The company commits to strictly comply with relevant regulations to avoid related party transactions that may harm the interests of the listed company and its shareholders[25] - The company guarantees not to transfer funds or profits from the listed company to its controlling enterprises, ensuring the protection of the listed company's legal interests[25] - The company has made commitments to maintain its independence and avoid any substantial competition with the listed company[29] - The company will ensure that any necessary related party transactions are conducted at market prices and in a fair manner[28] - The company has committed to achieving a total net profit of no less than CNY 16,000.00 million during the performance commitment period from 2020 to 2022[30] - The company guarantees the independence of its financial accounting department and the establishment of an independent financial management system[35] Operational Developments - The company is focused on maintaining independence in its operations, ensuring that it has the necessary assets, personnel, and qualifications to conduct business autonomously[36] - The company is actively pursuing market expansion and new product development strategies[45] - The company has signed a production order with BASF for 2-Chloropyridine, with products to be produced by a subsidiary[44] - The company is currently undergoing environmental acceptance for a facility used for the production of cyanopyridine, which has delayed the acquisition of property rights[49] - The company has established quality, environmental, and occupational health safety management systems, which are currently under certification[50] Risks and Challenges - The company reported a credit impairment loss of CNY 350,000.00 during the quarter, indicating potential risks in receivables[84] - The company has made provisions for impairment losses amounting to 12,780,401.68 yuan related to intangible assets as of December 31, 2009[58] - The company is actively assisting in the recovery of 30 million yuan related to the investment in Inner Mongolia Tongliao City[58] - If the asset recovery does not meet the expected amount, the company will compensate the difference in cash or equivalent assets[59]

Financial Performance - The company's operating revenue for the first half of 2020 was CNY 64,848,759.76, representing a 450.38% increase compared to CNY 11,782,613.02 in the same period last year[16]. - The net profit attributable to shareholders of the listed company reached CNY 17,128,340.26, a significant increase of 520.20% from a loss of CNY 4,076,269.72 in the previous year[16]. - The basic earnings per share improved to CNY 0.0530, compared to a loss of CNY 0.0126 per share in the same period last year, marking a 520.63% increase[16]. - The company achieved operating revenue of 64.8488 million yuan and a net profit attributable to the parent company of 17.1283 million yuan during the reporting period[26]. - The company achieved operating revenue of 64.88 million yuan and a net profit of 17.12 million yuan, an increase of 21.20 million yuan compared to the same period last year[36]. - The company reported a significant increase in revenue for the first half of 2020, achieving a total of 1.2 billion CNY, representing a 15% growth compared to the same period last year[82]. - The company provided a positive outlook for the second half of 2020, projecting a revenue increase of 10% to 1.32 billion CNY, driven by new product launches and market expansion strategies[84]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 743,071,838.68, up 209.11% from CNY 240,391,225.91 at the end of the previous year[16]. - The net assets attributable to shareholders of the listed company increased to CNY 92,358,682.98, a rise of 22.76% from CNY 75,234,542.75 at the end of the previous year[16]. - The company's total liabilities reached CNY 524,266,778.17, compared to CNY 152,363,231.59 previously[195]. - Current liabilities rose to CNY 516,841,901.00, compared to CNY 138,561,417.96 previously[195]. - Owner's equity increased to CNY 218,805,060.51, up from CNY 88,027,994.32[196]. Cash Flow - The company reported a net cash flow from operating activities of CNY -14,026,588.44, a decline of 604.40% compared to CNY 2,780,855.10 in the previous year[16]. - Investment activities generated a net cash flow of CNY 17,309,842.51, resulting from significant asset restructuring[41]. - The company’s total assets included cash and cash equivalents of CNY 20,303,968.84, which increased from CNY 2,886,732.39, marking a rise in proportion to total assets[49]. Business Strategy and Operations - The company completed a major asset purchase of 51% equity in Cangzhou Lingang Yano Chemical Co., Ltd. and sold 84.156% equity in Lanzhou Tongchuang Jiaye Real Estate Development Co., Ltd. in June 2020[28]. - The company’s transition from real estate to fine chemicals positions it in a more profitable sector, focusing on the development and sale of pharmaceutical and agricultural intermediates[26]. - The company is actively seeking suitable targets for mergers and acquisitions to deepen its strategic goals in biopharmaceuticals and fine chemicals[38]. - The company plans to enhance internal control and risk management systems to improve operational performance and compliance[37]. - The company aims to strengthen its long-term development strategy, focusing on the biopharmaceutical, health, and new chemical sectors[39]. Market and Industry Trends - The global agricultural chemical market is characterized by high capital intensity and technological requirements, leading to increased mergers and acquisitions to enhance competitiveness[33]. - The market share of the top five global agricultural chemical companies increased from 48.2% in 1998 to approximately 60% in 2017, indicating a trend towards industry consolidation[34]. - The company is focused on sustainability initiatives, with plans to invest 20 million CNY in green building technologies by the end of 2020[84]. Legal and Compliance - The company has fulfilled its commitments regarding legal compliance and has no foreseeable administrative penalties or criminal charges[81]. - The company has faced multiple lawsuits, all of which have been dismissed in favor of the company[81]. - The company has committed to ensuring that all information provided for the transaction is true, accurate, and complete, with no false records or misleading statements[90]. - The company has established an independent governance structure to prevent institutional overlap with controlled enterprises[94]. Risks and Challenges - The company has outlined potential risks and countermeasures in its report, emphasizing the importance of risk awareness for investors[4]. - The company faces risks related to performance compensation and share repurchase obligations due to the acquisition of Yanuo Biological, which may affect future earnings stability[66]. - Environmental and safety risks are heightened due to the nature of the fine chemical industry, with potential increases in compliance costs impacting profitability[70]. - The company anticipates challenges in integrating operations post-acquisition, which may affect overall business performance if not managed effectively[69]. Shareholder and Governance - The controlling shareholder, Lanzhou Asia-Pacific Industrial Group, holds a 9.95% stake in the company, while the actual controller, Zhu Quanzhu, will not transfer control within three years post-transaction[96]. - The company has committed to minimizing related party transactions and ensuring compliance with legal and regulatory requirements[93]. - The company guarantees independent tax compliance and financial decision-making without external interference[94]. Environmental and Sustainability Initiatives - The company has implemented 16 sets of air pollution control facilities to manage emissions from production processes[139]. - The company has received recognition as a "provincial-level green factory" and is applying for funding subsidies for its RTO technology[142].

Financial Performance - The company's operating revenue for 2019 was ¥13,911,871.59, a decrease of 63.12% compared to ¥37,721,516.23 in 2018[16] - The net profit attributable to shareholders was -¥10,180,311.64, representing a decline of 192.53% from ¥11,002,564.38 in the previous year[16] - The net cash flow from operating activities was -¥6,471,871.18, a drop of 169.97% compared to ¥9,249,396.33 in 2018[17] - The basic earnings per share were -¥0.0315, down 192.65% from ¥0.0340 in 2018[17] - The total operating cost for 2019 was ¥13,464,038.06, down 60.65% from ¥34,219,149.43 in 2018[42] - The gross profit margin for the real estate sector was 7.56%, a decline of 1.72% compared to the previous year[39] - The company reported a total revenue of 13.91 million yuan for the year 2019, with a net profit attributable to shareholders of -10.18 million yuan, a decrease of 21.18 million yuan compared to the previous year[32] Assets and Liabilities - Total assets increased by 21.12% to ¥240,391,225.91 at the end of 2019, compared to ¥198,474,606.91 at the end of 2018[17] - The net assets attributable to shareholders decreased by 11.92% to ¥75,234,542.75 from ¥85,414,854.39 in 2018[17] - The company has a financing balance of ¥3,500 million with a cost of 16.8%[35] - The company’s short-term borrowings increased to ¥35,000,000.00, representing 14.56% of total assets, due to new borrowings in the current year[51] - The company reported a total estimated liability of 4,726,147.18 yuan related to ongoing litigation as of December 31, 2018[94] Operational Challenges - The company has faced significant operational challenges, leading to a substantial decline in both revenue and profit margins[16] - Future plans and strategies to address these challenges are detailed in the report, highlighting potential risks and countermeasures[4] - The company is facing significant uncertainty regarding its ongoing operations due to slow progress in Area B development, which is hindered by resident relocations and funding issues[61] - The company is actively pursuing financing through multiple channels to address its cash flow challenges and support the development of Area B[62] Business Strategy and Transformation - The company aims to improve its sustainable operating capacity by transitioning into the biopharmaceutical, health, and new chemical sectors while maintaining its real estate business[30] - The company is transitioning from real estate development to the biopharmaceutical, health, and new chemical industries, actively seeking suitable acquisition targets[59] - The company plans to achieve a sales revenue of ¥39 million in 2020[34] - The company is actively planning the development of Area B of the project, although progress is slow due to resident relocation and funding issues[26] Governance and Management - The company has implemented measures to enhance internal control and compliance, focusing on asset restructuring and team building[32] - The company has maintained a consistent board composition with no new appointments during the reporting period, indicating stability[166] - The management team has a diverse professional background, contributing to a well-rounded governance structure[169] - The company has not reported any significant changes in its operational strategy or market expansion plans during the reporting period[175] Legal and Compliance Issues - The company is currently involved in legal proceedings regarding asset recovery, which are still under review[74] - The company has faced multiple court orders regarding the freezing of its assets due to non-compliance with legal obligations[123] - The company is currently involved in a legal dispute with Gansu Fourth Construction Group, which may result in additional financial liabilities if not resolved[95] Shareholder Information - The total number of shares is 323,270,000, with 290,486,300 unrestricted shares representing 89.86%[150] - The largest shareholder, Beijing Dashi Investment Co., holds 9.97% of the shares, totaling 32,220,200[152] - The company has not implemented any share repurchase or reduction plans during the reporting period[151] Employee and Welfare Initiatives - The company has consistently emphasized the importance of employee welfare, including comprehensive health check-ups for staff[114] - The total number of employees in the company is 30, with 5 in finance, 3 in sales, and 3 in technology[180] - In 2019, the company focused on comprehensive training for all employees to enhance compliance awareness and ensure proper operation of the listed company[181]

海南亚太实业发展股份有限公司 2020 年第一季度报告全文 海南亚太实业发展股份有限公司 2020 年第一季度报告 2020-037 2020 年 04 月 1 海南亚太实业发展股份有限公司 2020 年第一季度报告全文 第一节 重要提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真 实、准确、完整，不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和 连带的法律责任。 所有董事均已出席了审议本次季报的董事会会议。 公司负责人马兵、主管会计工作负责人王斌及会计机构负责人(会计主管人 员)乔昕爱声明：保证季度报告中财务报表的真实、准确、完整。 2 海南亚太实业发展股份有限公司 2020 年第一季度报告全文 第二节 公司基本情况 一、主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □ 是 √ 否 | | 本报告期 | 上年同期 | 本报告期比上年同期增减 | | --- | --- | --- | --- | | 营业收入（元） | 0.00 | 9,040,629.63 | -100.00% | | 归属于上市公司股东的净利润（元） | 4,985,630.26 | -1, ...

Financial Performance - Operating revenue for the reporting period was CNY 0.00, representing a decline of 100% compared to the same period last year[8]. - Net profit attributable to shareholders of the listed company was a loss of CNY 2,462,748.62, a decrease of 117.90% year-on-year[8]. - Basic earnings per share were CNY -0.0076, down 117.84% compared to the same period last year[8]. - Operating revenue was 11,782,613.02 yuan, a decrease of 37.38% compared to 18,815,400.02 yuan in the same period last year[9]. - The estimated cumulative net profit for the year 2019 is projected to be a loss of between CNY 8.5 million and CNY 13.5 million, representing a decrease of 177.25% compared to the previous year's profit of CNY 11 million[55]. - The basic earnings per share are expected to be between CNY -0.0418 and CNY -0.0263, indicating a decline of 222.94% from the previous year's earnings of CNY 0.034 per share[55]. - The net profit for the period was a loss of CNY 7,077,736.69, compared to a profit of CNY 11,509,386.01 in the previous period[86]. - The company reported a total comprehensive income of -CNY 7,077,736.69 for the period, compared to CNY 11,509,386.01 in the previous period[86]. - The net profit for the third quarter was -3,548,563.42 CNY, compared to a profit of 12,085,914.65 CNY in the same period last year, indicating a significant decline[90]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 190,939,861.29, a decrease of 3.80% compared to the end of the previous year[8]. - Net assets attributable to shareholders of the listed company were CNY 78,875,836.05, down 7.66% year-on-year[8]. - The total assets of the company as of September 30, 2019, were CNY 190.94 million, down from CNY 198.47 million at the end of 2018[68]. - The total liabilities as of September 30, 2019, were CNY 99.28 million, slightly down from CNY 99.73 million at the end of 2018[69]. - The company's cash and cash equivalents stood at CNY 8.02 million as of September 30, 2019, compared to CNY 4.73 million at the end of 2018[66]. - The company's equity attributable to shareholders decreased from CNY 85.41 million at the end of 2018 to CNY 78.88 million as of September 30, 2019[69]. - The total liabilities of the company were CNY 99,732,121.52, with current liabilities accounting for CNY 85,930,307.89[103]. - The total current assets were CNY 157,543,225.49, with inventory valued at CNY 152,395,680.85[101]. Cash Flow - Cash flow from operating activities showed a net outflow of CNY -1,667,692.57, an increase of 77.97% in outflow compared to the previous year[8]. - Net cash flow from operating activities was -1,667,692.57 yuan, an improvement of 77.97% compared to -7,569,408.79 yuan in the same period last year, mainly due to mortgage repayments and pre-sale funds received[17]. - Net cash flow from financing activities was -552,922.41 yuan, an improvement of 96.74% from -16,962,973.86 yuan year-on-year, mainly due to reduced cash payments for debt repayment[18]. - The net cash flow from operating activities was -1,667,692.57 CNY, an improvement from -7,569,408.79 CNY in the same period last year[94]. - The cash flow from financing activities resulted in a net outflow of -552,922.41 CNY, an improvement from -16,962,973.86 CNY in the previous year[94]. Shareholder and Equity Information - The total number of ordinary shareholders at the end of the reporting period was 16,938[11]. - The company holds equity in Lanzhou Tongchuang Jiaye valued at RMB 13,422,689.10, which has been sealed by the Tianjin Second Intermediate People's Court[39]. - The company's equity attributable to shareholders was CNY 85,414,854.39, with an accumulated deficit of CNY -405,676,557.34[103]. Legal and Compliance Issues - The company received a civil ruling from the Beijing First Intermediate People's Court regarding the forced liquidation application for Blue View Home, stating that the case is under the jurisdiction of the court[28]. - The company has provided joint guarantee responsibilities for a bank loan of RMB 19,800,000, which has been overdue and involves judicial litigation[32]. - The Tianjin Second Intermediate Court ordered the freezing of RMB 11,422,689.10 in bank deposits due to a loan dispute involving the company and its subsidiaries[33]. - The court's execution notice required the company to fulfill its obligations or face forced execution, with a deadline for compliance[34]. - The company is currently involved in legal proceedings regarding asset recovery, which may impact financial performance[48]. Operational Challenges - The company faces significant uncertainties regarding its ongoing operations, including cash flow shortages and overdue bank loans[52]. - The company has overdue loans amounting to 14,878,600 yuan and has committed to provide funding to resolve this by July 31, 2019[53]. - The company is actively pursuing asset restructuring and management improvements to enhance operational capabilities[52]. - The company is focused on leveraging its platform advantages to expedite project development and resolve ongoing operational challenges[53].

Financial Performance - The company's operating revenue for the first half of 2019 was ¥11,782,613.02, a decrease of 16.59% compared to ¥14,125,862.86 in the same period last year[17]. - The net profit attributable to shareholders was a loss of ¥4,076,269.72, representing an 85.52% increase in loss compared to a loss of ¥2,197,155.00 in the previous year[17]. - The company reported a gross profit margin of 3.08% for the period, with operating costs at 11.42 million RMB[32]. - The company’s cash flow from operating activities improved by 134.85% to 2.78 million RMB compared to a negative cash flow in the previous year[37]. - The company reported a total comprehensive loss of CNY 2,654,349.64 for the first half of 2019, compared to a loss of CNY 2,153,234.57 in the same period of 2018, indicating a year-over-year increase in comprehensive loss of approximately 23.1%[143]. - The basic earnings per share for the first half of 2019 was CNY -0.0126, compared to CNY -0.0068 in the first half of 2018, indicating a decline in profitability per share[138]. Assets and Liabilities - The total assets at the end of the reporting period were ¥186,026,655.17, down 6.27% from ¥198,474,606.91 at the end of the previous year[17]. - The total liabilities decreased to CNY 91,612,017.79 from CNY 99,732,121.52, reflecting a reduction of about 8.5%[129]. - The company's equity attributable to shareholders decreased to CNY 81,338,584.67 from CNY 85,414,854.39, indicating a decline of approximately 4.5%[129]. - The company has overdue loans amounting to CNY 14.8786 million, with a commitment to repay by July 31, 2019, and an additional CNY 10 million by October 31, 2019[64]. - The company has outstanding debts totaling CNY 18,427,500, with CNY 14,878,100 of bank loans overdue, raising concerns about its ongoing viability[168]. Cash Flow - The net cash flow from operating activities improved to ¥2,780,855.10, a significant increase of 134.85% from a negative cash flow of ¥7,978,614.76 in the same period last year[17]. - The cash outflow from financing activities totaled 7,000,000.00 RMB, resulting in a net cash flow of -7,000,000.00 RMB from financing activities[150]. - The net increase in cash and cash equivalents was -1,367,263.76 RMB, with a closing balance of 23,402.09 RMB[150]. Strategic Developments - The company plans to actively develop the B District project, which has been renamed from the originally planned D District, but progress is slow due to resident relocation and funding issues[23]. - The company is currently involved in litigation regarding a loan guarantee, with a potential liability of CNY 13.422 million[69]. - The company is undergoing a major asset restructuring to transition into the pharmaceutical industry, with plans to acquire at least 70% of Chengdu Xinjie High-tech Development Co., Ltd.[95]. - The company is focused on enhancing its operational capabilities to resolve ongoing financial challenges[64]. Legal and Compliance Issues - The company has a significant legal risk related to a court-ordered freeze on assets worth 13,422,689.10 due to ongoing litigation[43]. - The company is under legal proceedings regarding the forced liquidation of assets, which may impact its financial position[59]. - The company has committed to recover 30 million yuan from Beijing Lanjingli Family Furniture Co., Ltd. and is actively pursuing legal action to ensure this recovery[59]. Shareholder Information - The total number of shares is 323,270,000, with 10.14% (32,783,700 shares) being subject to restrictions and 89.86% (290,486,300 shares) being unrestricted[110]. - The largest shareholder, Beijing Dashi Investment Co., Ltd., holds 9.97% (32,220,200 shares) of the total shares, with no changes during the reporting period[112]. - The company has not experienced any changes in its controlling shareholder or actual controller during the reporting period[114]. Market Conditions - The company has a high brand recognition and market acceptance in the local area, although sales have been challenging due to a sluggish market[23]. - The company is currently developing the "Asia-Pacific Rose Garden" project, but sales have been slow due to a lack of market activity, with remaining unsold properties and parking spaces[168]. Future Outlook - The estimated net profit for the period from January to September 2019 is expected to be a loss of between 6 million and 4.8 million, primarily due to a decrease in available housing sources[50]. - The company plans to achieve sales revenue of 28 million RMB and cash collection of 12 million RMB in the second half of 2019[32]. - The company is expected to continue monitoring its cash flow and investment strategies moving forward[153].

Financial Performance - The company's operating revenue for 2018 was ¥37,721,516.23, a decrease of 18.26% compared to ¥46,147,810.94 in 2017[16] - The net profit attributable to shareholders in 2018 was ¥11,002,564.38, representing a significant increase of 227.93% from a loss of ¥8,600,632.59 in 2017[16] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥8,170,576.25, a slight improvement of 7.56% from -¥8,839,027.17 in 2017[16] - The net cash flow from operating activities decreased by 37.37% to ¥9,249,396.33 compared to ¥14,767,153.41 in the previous year[18] - Basic and diluted earnings per share increased by 213.33% to ¥0.034 from a loss of ¥0.03 in the previous year[18] - The weighted average return on equity improved to 13.77%, up from -10.93% in the previous year, representing a 24.70% increase[18] - Total assets decreased by 21.55% to ¥198,474,606.91 from ¥252,987,702.89 at the end of the previous year[18] - Net assets attributable to shareholders increased by 14.79% to ¥85,414,854.39 from ¥74,412,290.01 at the end of the previous year[18] Dividend Policy - The company plans not to distribute cash dividends or issue bonus shares[6] - The company did not distribute cash dividends for the fiscal year 2018, with a total cash dividend amount of 0.00[72] - The company reported a net profit available for distribution to ordinary shareholders, but no cash dividend distribution plan was proposed[73] - The company has not distributed any cash dividends or bonus shares over the past three years, indicating potential liquidity issues[71] Shareholder Information - The company’s major shareholder, Lanzhou Yatai Industrial Group, held 54,740,795 shares, accounting for 16.93% of the total shares as of December 31, 2018[16] - The total number of shares is 323,270,000, with 10.14% being limited shares and 89.86% being unrestricted shares[134] - The number of shareholders increased from 19,516 to 21,897 during the reporting period[136] - The largest shareholder, Lanzhou Asia-Pacific Industrial Group Co., Ltd., holds 32,177,295 shares, accounting for 9.95% of total shares[138] - The second largest shareholder, Lanzhou Taihua Investment Holding Co., Ltd., holds 22,000,000 shares, representing 6.98% of total shares[138] Legal and Regulatory Issues - The company is currently facing significant operational risks due to its reliance on the "Asia-Pacific Rose Garden" real estate project, with limited cash flow and ongoing challenges in project development[64] - The company is involved in multiple legal disputes, including a lawsuit with a bank that has resulted in the seizure of 13.42 million yuan in equity, which may lead to further litigation risks[65] - The company has a contingent liability of 1,342,000 yuan related to a lawsuit involving its subsidiary Tianjin Green Source[89] - The company is involved in a legal case with Tianjin Huaheng Xinrui Asset Management Co., with a debt amounting to 2,800,000 yuan[89] - The company has received a court ruling requiring it to pay 4,167,832.18 yuan plus interest to Gansu Fourth Construction Group Co., Ltd. for project payments[93] Business Strategy and Transformation - The company plans to transform its business towards the pharmaceutical industry and has signed a memorandum to acquire at least 70% of Chengdu Xinhengchuang Pharmaceutical Co., Ltd.[63] - The company is focused on expanding its market presence in Lanzhou, leveraging its brand recognition and development experience in the local real estate sector[26] - The company has actively participated in regulatory meetings and is working on mergers and acquisitions to promote business transformation[34] - The company plans to achieve a sales revenue of CNY 40 million in 2019, with a cash return target of CNY 20 million[33] Financial Management and Audit - The company has engaged Lianda Certified Public Accountants for auditing, which provided an unqualified opinion with emphasis on certain matters[5] - The company received a non-standard audit report from Lianda CPA, which reflects the company's financial status and potential risks[82] - The company’s financial statements were prepared in accordance with accounting standards, reflecting its financial position and operating results accurately[188] - The audit identified key audit matters, including revenue recognition and debt restructuring, which were deemed critical for the financial statements.[192] Operational Challenges - The company has faced challenges in selling its remaining properties due to a lack of an active market, leading to a severe shortage of available housing.[190] - The company’s "Asia-Pacific Rose Garden" project has seen slow development in zones B-D due to resident relocations and financial constraints, with only a small number of shops and parking spaces remaining for sale in zone A.[190] - The company has acknowledged that commitments made regarding "Blue View Home" and "Tongliao Land" do not meet regulatory requirements due to legal obstacles[78] Employee and Management Structure - The total number of employees in the company is 28, with 15 in the parent company and 13 in major subsidiaries[161] - The company has a total of 5 financial personnel and 17 administrative personnel among its employees[162] - Several senior management personnel, including the financial director, left the company for personal reasons in April 2018[149] - The current chairman and general manager, Ma Bing, has been with the company since 2016 and has held various positions[150] Governance and Compliance - The company has established a governance structure that complies with relevant laws and regulations, ensuring independent operation from its controlling shareholder[168] - The attendance rate for the annual shareholder meeting was 17.00%, while the attendance for the first extraordinary shareholder meeting was 16.89%[169] - Independent directors attended all required board meetings and did not raise any objections to company matters during the reporting period[171] - The company reported zero significant internal control deficiencies during the reporting period[178] Related Party Transactions - The company reported a total of 14.01 million yuan in related party transactions for the year, with a breakdown of 2.11 million yuan for property management fees and 1.01 million yuan for water and electricity fees[98] - The company has a total of 39.53 million yuan in payables to related parties, with no repayments made during the reporting period[102] - A guarantee of 40 million yuan was provided for a bank loan to a subsidiary, with 20 million yuan remaining as of December 17, 2018[103] Future Outlook - The company is optimistic about its future development and capital market conditions, which influenced its shareholding increase plan[79] - The company has plans to assist in recovering related assets worth 30 million yuan, with a current impairment provision of 12,780,401.68 yuan for intangible assets[76] - The company’s management has disclosed plans to address the uncertainties affecting its ongoing operations in the financial statements.[190]

Financial Performance - The company's operating revenue for Q1 2019 was ¥9,040,629.63, representing a 16.29% increase compared to ¥7,773,986.91 in the same period last year[8] - The net profit attributable to shareholders was -¥1,505,923.44, a decrease of 9.77% from -¥1,371,944.24 year-on-year[8] - The company's basic earnings per share were -¥0.0047, a decline of 11.90% compared to -¥0.0042 in the same period last year[8] - The company expects a net loss attributable to shareholders of between 4 million and 6 million yuan for the first half of 2019, representing a decrease of 117.43% compared to the same period last year[25] - Basic earnings per share are projected to be between -0.0186 and -0.0124 yuan, indicating a decline of 172.95% year-over-year[25] - Net loss for Q1 2019 was CNY -1,591,863.02, compared to a net loss of CNY -1,362,015.81 in Q1 2018, reflecting a decline in profitability[46] - Total comprehensive income for the first quarter was -1,005,673.91 CNY, compared to -1,288,091.85 CNY in the same period last year, reflecting a 22% improvement[50] Cash Flow and Operating Activities - The net cash flow from operating activities improved significantly to ¥1,979,100.06, a 290.52% increase from -¥1,038,793.06 in the previous year[8] - Cash received from sales of goods and services increased by 267.41% to ¥6,760,617.21 from ¥1,840,058.10 in the previous year[17] - The company reported cash payments for operating activities of CNY 1,667,955.13, an increase of 23.96% compared to the previous year[18] - Operating cash flow for the period was 1,979,100.06 CNY, a significant recovery from -1,038,793.06 CNY in the previous year[54] - The company reported cash inflows from operating activities totaling 6,927,139.96 CNY, compared to 2,447,201.76 CNY in the same period last year, marking an increase of approximately 183%[53] - Cash outflows from operating activities were 4,948,039.90 CNY, compared to 3,485,994.82 CNY in the previous year, representing an increase of about 42%[53] Assets and Liabilities - Total assets at the end of the reporting period were ¥188,476,372.16, down 5.04% from ¥198,474,606.91 at the end of the previous year[8] - As of March 31, 2019, total current assets amounted to 147,870,189.88 yuan, down from 157,543,225.49 yuan at the end of 2018, reflecting a decrease of approximately 6.5%[36] - The company's total assets as of March 31, 2019, were 188,476,372.16 yuan, compared to 198,474,606.91 yuan at the end of 2018, indicating a decline of about 5.0%[36] - Total liabilities decreased from 99,732,121.52 yuan at the end of 2018 to 91,325,829.01 yuan as of March 31, 2019, a reduction of approximately 8.5%[37] - The company's equity attributable to shareholders decreased from 85,414,854.39 yuan at the end of 2018 to 83,908,930.95 yuan as of March 31, 2019, a decline of about 1.8%[38] Management and Expenses - The company's management expenses decreased by 29.03% to ¥1,205,712.25 from ¥1,698,949.51 year-on-year[16] - The financial expenses were reduced by 46.22% to ¥364,766.16, down from ¥678,259.14, due to a decrease in loan principal and corresponding interest[16] - Total operating costs for Q1 2019 were CNY 10,632,492.65, up 16.4% from CNY 9,136,002.72 in the previous year[44] Legal and Asset Recovery - The company is actively pursuing the recovery of CNY 30 million related to the "Blue Scenery Home" investment asset, with legal proceedings ongoing[20] - The company has committed to compensating for any shortfall in asset recovery, with a guarantee of CNY 30 million in cash or equivalent assets if recovery efforts fail[23] - The company plans to assist in the disposal of the "Tongliao Land" asset, which is still pending resolution[20] - The company is currently in the process of appealing a court decision regarding the forced liquidation of "Blue Scenery Home" assets[24] - The company has not yet completed the disposal of the Tongliao land, which remains a focus for future actions[20] Other Information - The company reported no non-recurring gains or losses during the reporting period[8] - The company has not engaged in any securities or derivative investments during the reporting period[26][27] - There were no non-operating fund occupations by controlling shareholders or related parties during the reporting period[31] - The first quarter report was not audited[59]